ES2061607T3 - INSTANT ORAL RELEASE CAPSULE, WITH NIFEDIPINE CONTENT. - Google Patents

INSTANT ORAL RELEASE CAPSULE, WITH NIFEDIPINE CONTENT.

Info

Publication number
ES2061607T3
ES2061607T3 ES88118596T ES88118596T ES2061607T3 ES 2061607 T3 ES2061607 T3 ES 2061607T3 ES 88118596 T ES88118596 T ES 88118596T ES 88118596 T ES88118596 T ES 88118596T ES 2061607 T3 ES2061607 T3 ES 2061607T3
Authority
ES
Spain
Prior art keywords
solution
nifedipine
release capsule
instant oral
oral release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88118596T
Other languages
Spanish (es)
Inventor
Walter Wimmer
Miller Ronald Brown
Mortimer David Sackler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6340247&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2061607(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Application granted granted Critical
Publication of ES2061607T3 publication Critical patent/ES2061607T3/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

The invention concerns an instant oral-release capsule containing an aqueous or aqueous alcoholic solution of nifedipine, containing a polyalkylene glycol and a polyoxyethylene ester component, the amount of the ester component in the solution being sufficient to prevent precipitation of nifedipine in the mouth of a patient after release of the solution from the capsule. Preferably, the ester component is an ethoxylated hydrogenated castor oil Cremophor RH40. The solution may further contain a second glycol component, especially glycerol.
ES88118596T 1987-11-11 1988-11-09 INSTANT ORAL RELEASE CAPSULE, WITH NIFEDIPINE CONTENT. Expired - Lifetime ES2061607T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873738236 DE3738236A1 (en) 1987-11-11 1987-11-11 BIT CAPSULE

Publications (1)

Publication Number Publication Date
ES2061607T3 true ES2061607T3 (en) 1994-12-16

Family

ID=6340247

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88118596T Expired - Lifetime ES2061607T3 (en) 1987-11-11 1988-11-09 INSTANT ORAL RELEASE CAPSULE, WITH NIFEDIPINE CONTENT.

Country Status (10)

Country Link
US (1) US5200192A (en)
EP (1) EP0315960B1 (en)
JP (1) JPH01238528A (en)
AT (1) ATE101516T1 (en)
AU (1) AU616693B2 (en)
CA (1) CA1312549C (en)
DE (2) DE3738236A1 (en)
ES (1) ES2061607T3 (en)
IE (1) IE63182B1 (en)
ZA (1) ZA888441B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3121080B2 (en) * 1991-12-19 2000-12-25 アール・ピー・シーラー コーポレイション Encapsulation solution
IT1263840B (en) * 1993-03-30 1996-09-04 Giuseppe Furiosi ORAL FORMULATIONS OF UBIDECARENONE IN THE FORM OF CAPSULES
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
PT910339E (en) * 1996-04-12 2005-05-31 Novadel Pharma Inc AEROSOL POLAR BUCAL
IT1284604B1 (en) * 1996-09-27 1998-05-21 Roberto Valducci CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION CONTAINING NIFEDIPINE AS THE ACTIVE SUBSTANCE
US7632517B2 (en) 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US20030077227A1 (en) 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
WO1999016417A1 (en) 1997-10-01 1999-04-08 Flemington Pharmaceutical Corporation Buccal, polar and non-polar spray or capsule
US20040136914A1 (en) 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
US20030185761A1 (en) 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US6168806B1 (en) 1999-03-05 2001-01-02 Fang-Yu Lee Orally administrable nifedipine pellet and process for the preparation thereof
DE19922537A1 (en) * 1999-05-10 2000-11-16 Roland Bodmeier Dosage form for application in body openings
US20040115134A1 (en) * 1999-06-22 2004-06-17 Elan Pharma International Ltd. Novel nifedipine compositions
SE9902742D0 (en) * 1999-07-20 1999-07-20 Astra Ab New pharmaceutical formultion
WO2002015887A1 (en) * 2000-08-17 2002-02-28 Machines Industrielles Etablissements Consumable container
WO2002087543A1 (en) * 2001-05-01 2002-11-07 Biozone Laboratories, Inc. Sustained release formulations for nifedipine, dextromethorphan, and danazol
DE10142417A1 (en) * 2001-08-31 2003-03-20 Molecular And Clinical Drug Re drug
DE10142416A1 (en) * 2001-08-31 2003-03-20 Molecular And Clinical Drug Re Process for the preparation of solutions
US20070219131A1 (en) * 2004-04-15 2007-09-20 Ben-Sasson Shmuel A Compositions capable of facilitating penetration across a biological barrier
WO2006097793A2 (en) 2004-04-15 2006-09-21 Chiasma, Ltd. Compositions capable of facilitating penetration across a biological barrier
US7530804B2 (en) * 2004-12-07 2009-05-12 Mcneil-Ppc, Inc. System and process for providing at least one opening in dosage forms
JP2011510005A (en) * 2008-01-18 2011-03-31 ダウ グローバル テクノロジーズ インコーポレイティド Method for enhancing water solubility of poorly soluble active substances using methoxypolyethylene glycol
MX2011002836A (en) 2008-09-17 2011-04-28 Chiasma Inc Pharmaceutical compositions and related methods of delivery.
EP2717852B1 (en) 2011-06-08 2019-05-08 LTS LOHMANN Therapie-Systeme AG Edible oral strip or wafer dosage form containing ion exchange resin for taste masking
WO2016126830A1 (en) 2015-02-03 2016-08-11 Chiasma Inc. Method of treating diseases
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2209526C3 (en) * 1972-02-29 1980-02-28 Bayer Ag, 5090 Leverkusen Coronary therapeutic agent in the form of gelatine capsules
SU432703A3 (en) * 1971-08-24 1974-06-15 Фридрих Боссерт, Вульф Фатер, Курт Бауер
DE3237814A1 (en) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. WATER-FREE EMULSIONS AND USE THEREOF
DE3307422A1 (en) * 1983-03-03 1984-09-06 Bayer Ag, 5090 Leverkusen LIQUID PREPARATIONS OF DIHYDROPYRIDINES, A METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN THE FIGHT AGAINST DISEASES
DE3437599A1 (en) * 1984-10-13 1986-04-17 Dolorgiet GmbH & Co KG, 5205 St Augustin SOFT GELATINE CAPSULES CONTAINING IBUPROFEN AND METHOD FOR THE PRODUCTION THEREOF
US4689233A (en) * 1986-01-06 1987-08-25 Siegfried Aktiengesellschaft Coronary therapeutic agent in the form of soft gelatin capsules
SE8601624D0 (en) * 1986-04-11 1986-04-11 Haessle Ab NEW PHARMACEUTICAL PREPARATIONS
GB8629761D0 (en) * 1986-12-12 1987-01-21 Harris Pharma Ltd Capsules
EP0272336B1 (en) * 1986-12-18 1991-10-23 Kurt H. Prof. Dr. Bauer Nifidipine concentrate stabilized against the influence of light, and method for its preparation

Also Published As

Publication number Publication date
ATE101516T1 (en) 1994-03-15
DE3887826D1 (en) 1994-03-24
DE3738236A1 (en) 1989-05-24
AU616693B2 (en) 1991-11-07
ZA888441B (en) 1989-08-30
CA1312549C (en) 1993-01-12
EP0315960A1 (en) 1989-05-17
IE883378L (en) 1989-05-11
JPH01238528A (en) 1989-09-22
DE3887826T2 (en) 1994-09-22
AU2499388A (en) 1989-05-11
IE63182B1 (en) 1995-03-22
US5200192A (en) 1993-04-06
EP0315960B1 (en) 1994-02-16

Similar Documents

Publication Publication Date Title
ES2061607T3 (en) INSTANT ORAL RELEASE CAPSULE, WITH NIFEDIPINE CONTENT.
ES2120516T3 (en) PREPARATION OF PHARMACEUTICAL COMPOSITIONS CONTAINING A CALCITONIN.
PL300194A1 (en) Interferon conjugate, method of obtaining same and pharmaceutical composition containing it
AU2059088A (en) A device for the administration of implants
ZA836582B (en) Constant release rate solid oral dosage formulations of drugs having a pka7-10 and an aqueous solubility of 15-100g/ml water
DE69105040T2 (en) Medicines for impotence.
IE812354L (en) Prostaglandin capsule
PH25286A (en) Sustained release drug preparation
IL86395A (en) Pharmaceutical compositions with improved bioavailability containing flunarizine and polyethoxylated castor oil
IE893718L (en) Pharmaceutical Compositions
DK0657164T3 (en) Pharmaceutical compositions containing staurosporine derivatives and a polyalkylene glycol glyceride
FR2618670B1 (en) MEDICINAL PREPARATION BASED ON ESSENTIAL OILS, AS WELL AS DENTAL AND CHEWING GUM CONTAINING THE SAME
AU2072088A (en) Agent containing salicylic acid for treating lepidosis
PH25009A (en) Antitussive liquid compositions containing phenol
KR900014382A (en) (S) -7- (3-amino-1-pyrrolidinyl) -1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-naphthyridine-3-carboxylic acid
SG49770A1 (en) Pharmaceutical preparation
ATE116547T1 (en) MEDICINAL SUSPENSION CONTAINING ALGIC ACID.
DE3778826D1 (en) PERMANENT THERAPEUTIC COMPOSITIONS BASED ON HYDROPHOBIC VEGETABLE OIL AND METHOD FOR THE PRODUCTION THEREOF.
EP0539516A4 (en)
JPS56166108A (en) Base for cosmetic and medicine
UA29645A (en) Natural drug (variants)
GR860962B (en) Tobacco compositions method and device for releasing essentially pure nicotine

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 315960

Country of ref document: ES